Has interest in secondary prevention increased among physicians after the 4S study?

Scandinavian Cardiovascular Journal

Volumn 34, Issue 2, 2000, Pages 164-167

  Attebring, M F ^a   Hartford, M ^a   Berndt, A K ^a   Herlitz, J ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Ischemic heart disease; Lipid lowering; Secondary prevention

Indexed keywords

ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL OBSERVATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY RISK; HOSPITALIZATION; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SECONDARY PREVENTION; SWEDEN; TRANSLUMINAL CORONARY ANGIOPLASTY; UNIVERSITY HOSPITAL;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTILIPEMIC AGENTS; CORONARY ARTERY BYPASS; CORONARY DISEASE; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSICIAN'S PRACTICE PATTERNS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 0034460242     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017430050142189     Document Type: Article

References (25)

1. Disease-free intervals after partial ileal bypass in patients with coronary heart disease and hypercholesterolemia: Report from the program on the surgical control of the hyperlipidemias (POSCH)
2. Effects of mono-therapy with an HMGCoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography: The Canadian coronary atherosclerosis intervention trial
3. Effect of simvastatin on coronary atheroma: A multicentre antiatheroma study
4. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The regression growth evaluation statin study (REGRESS)
5. Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events
6. Prevention of coronary heart disease in clinical practice: A commentary on current treatment patterns in six European countries in relation to published recommendations
7. Risk indicators for recurrence among patients with coronary artery disease. Problems associated with their modification
8. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin survival study (4S)
9. West of Scotland coronary prevention study: Identification of high-risk groups and comparison with other cardiovascular intervention trials
10. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
11. What happened to intravenous atenolol in acute myocardial infarction?
12. Beta blockers prevent cardiac death following a myocardial infarction: So why are so many infarct survivors discharged without beta blockers
13. Treatment with beta-adrenergic blocking agents after myocardial infarction. From randomized trials to clinical practice
14. Clinical and economic factors in the treatment of congestive heart failure
15. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17 187 cases of suspected acute myocardial infarction
16. The appropriateness of performing coronary angiography and coronary artery revascularization in a Swedish population
17. Factors associated with the use of various medications among patients with severe coronary artery disease
18. Regional variation across the United States in the management of acute myocardial infarction
19. The use of nitrates, calcium channel blockers and ACE inhibitors in primary care in the Northern Region: A pharmacoepidemiological study
20. Regional attitudes of generalists, specialists, and subspecialists about management of atrial fibrillation
21. Coronary revascularisation: Why do rates vary geographically in the UK?
22. Comparison of medical care and one- and 12-month mortality of hospitalized patients with acute myocardial infarction in Minneapolis-St. Paul, Minnesota, United States of America and Göteborg, Sweden
23. Implementation of the 4S study in first myocardial infarction
24. Effect of metoprolol CR/XL in chronic heart failure; Metoprolol CR/XL. Randomised intervention trial in congestive heart failure (MERIT-HF)